Open access · CC-BY
via OpenAlex
Senescent Mesenchymal Stromal Cells Drive Stem Cell Aging Through Dysregulated Chemokine Synthesis
Shaianne N. Stein, Lorena R. Braid
Aging Cell · 2026
Epigenetic alterations
Cellular senescence
Stem-cell exhaustion
Altered intercellular communication
Chronic inflammation
Senolytics
Abstract
ABSTRACT Aging is accompanied by a progressive decline in tissue regenerative capacity, driven by intrinsic stem cell dysfunction and age‐associated deterioration of the surrounding stem cell niche. Mesenchymal stromal cells (MSCs) are ubiquitous components of stem cell niches, where they integrate structural, metabolic, inflammatory, and paracrine cues to regulate stem cell quiescence, activation, and differentiation. With age, MSCs undergo functional decline and senescence(definition), altering their secretory and signaling profiles. Across tissues, MSC senescence emerges as an intermediate amplifier of aging: molecular, metabolic, epigenetic, and inflammatory stressors promote the senescent state, which converts these upstream insults into chemokine imbalance, chronic inflammation, and progressive loss of stem cell support. Here, we synthesize classical and emerging literature to examine how age‐associated changes in MSC chemokine synthesis contribute to stem cell aging, and we propose a synthesis‐based model in which MSCs translate age‐associated stressors into altered chemokine repertoires that disrupt stem cell‐supportive signaling. We also discuss therapeutic strategies, including chemokine‐directed therapies, senolytics(definition), and MSC rejuvenation, that may restore regenerative capacity by normalizing MSC‐derived signals. Together, the evidence identifies dysregulated chemokine synthesis as a conserved mechanism linking tissue‐resident MSC aging to declining regenerative capacity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.70780
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Stein, S.N., & Braid, L.R. (2026). Senescent Mesenchymal Stromal Cells Drive Stem Cell Aging Through Dysregulated Chemokine Synthesis. <em>Aging Cell</em>. https://doi.org/10.1111/acel.70780
Vancouver
Stein SN, Braid LR. Senescent Mesenchymal Stromal Cells Drive Stem Cell Aging Through Dysregulated Chemokine Synthesis. Aging Cell. 2026. doi:10.1111/acel.70780.
BibTeX
@article{shaianne2026Senesc,
title = {Senescent Mesenchymal Stromal Cells Drive Stem Cell Aging Through Dysregulated Chemokine Synthesis},
author = {Shaianne N. Stein and Lorena R. Braid},
journal = {Aging Cell},
year = {2026},
doi = {10.1111/acel.70780},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging cell 2026
Open access · OA
Senescent Mesenchymal Stromal Cells Drive Stem Cell Aging Through Dysregulated Chemokine Synthesis.
Aging and Disease 2023
Open access · CC-BY
Mesenchymal Stem Cell Senescence during Aging:From Mechanisms to Rejuvenation Strategies
Frontiers in Cell and Developmental Biology 2023
Open access · CC-BY
Targeting the stem cell niche micro-environment as therapeutic strategies in aging
Europe PMC (PubMed Central) 2012
Preprint · OA
Mesenchymal stem cells, aging and regenerative medicine.
Biomolecules 2025
Open access · CC-BY
Rejuvenation of Bone Marrow Mesenchymal Stem Cells: Mechanisms and Their Application in Senile Osteoporosis Treatment
Stem cells and development 2026
Citation only